Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer

Industry veteran added to complement co-founders Nicholas Flytzanis, Ph.D. and Nick Goeden, Ph.D., to build on Company's excellence in next-generation gene therapy science and bolster efforts to advance novel platform to patients Flytzanis will continue... Biopharmaceuticals, Regenerative Medicine, Personnel Capsida Biotherapeutics, gene therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news